Our Work

We are inspired by companies, researchers and entrepreneurs who want to make a true difference

We work with great clients and great people. Catalyze supports a variety of Life Sciences developments including, but not limited to, diagnostics, pharmaceuticals, medical devices and healthcare solutions. Our clients range from researchers at academic hospitals and universities, to non-profit organizations, start-ups, SMEs and larger companies. This includes clients who focus on their own product development, but also strong partnerships with the services industry like CROs, formulation partners, clinical trials experts and regulatory experts.

View some example cases

 

Radiobotics – Celebrating ranking as a top project with Eurostars

Radiobotics – Celebrating ranking as a top project with Eurostars

An interview with Stine Mølgaard Sørensen, Co-founder and COO of Radiobotics  Eurostars saw the potential of Radiobotics AI in X-ray screening to entirely disrupt the radiology world. They achieved their top-ranking position with Eurostars by making routine musculoskeletal radiology and diagnostics more efficient with their breakthrough AI technology, effectively improving the quality and freeing up…

Preventicus – Stroke prevention starts at the touch of your fingertips

Preventicus – Stroke prevention starts at the touch of your fingertips

Interview with Dr. Thomas Huebner, Founder and Managing Director of Preventicus GmbH. Following their success in securing an SME Instrument Phase II grant, Dr. Thomas Huebner sat down with us to tell us the story of how Preventicus and Health Tech are enabling us, and our doctors, with greater power over our healthcare decisions, and…

Labonovum – simplifying laboratory analysis for patients

Labonovum – simplifying laboratory analysis for patients

Interview with Dennis Poland, Chief Innovation Officer (CIO) of Labonovum novum (plural novums or nova) A new feature, a novelty. Despite great advancements in clinical analysis laboratory for the past half century, not much has changed for patients – who still have to endure the same procedures to collect blood for analysis. Labonovum has recently been awarded €3 million with…

iPSpine – the veterinarian trying to solve the problem of low back pain

iPSpine – the veterinarian trying to solve the problem of low back pain

Interview with Professor Marianna Tryfonidou, from the Faculty of Veterinary Medicine of the Utrecht University The iPSpine project was recently awarded €15 million under the Horizon 2020 programme, towards researching a solution for chronic lower back pain. The huge public-private consortium is comprised of 20 partners, and is coordinated by the Faculty of Veterinary Medicine…

Khondrion – in search of treatment for mitochondrial diseases

Khondrion – in search of treatment for mitochondrial diseases

Interview with Jan Smeitink, CEO of Khondrion Eight years ago, Jan Smeitink looked at himself in the mirror and decided he is going to change the world. Today, Jan is the Chief Executive Officer of Khondrion and is starting Phase 2b clinical trials for his revolutionary drug, KH176 – which might well become the first…

Nutrileads

Nutrileads

Meet Nutrileads – one of today’s leading innovative companies to have recently received the prestigious SME Phase 2 Award. Although winning such a grant can feel “like winning the lottery”, the success of Nutrileads is much more than luck. To learn more about their inspiring story we interviewed Erik Dam, the Chief Business Office of…

TRiCares

TRiCares

TRiCares, a French-German medical device company, has been awarded a prestigious Horizon 2020 SME Instrument Phase 2 grant to bring the unique heart valve replacement system to clinical readiness.

REACTION!

REACTION!

The REACTION! Project comprises a direct-aid response to the EBOLA crisis in 2015. The project was initiated by an international project team to provide rapid aid and health-care to the Ebola-infected population in Guinea, and by directly collecting rapid evidence of the efficacy of Favipiravir in reducing the mortality and Ebola viral load in the…